| 738488 |
FRONTIERS IN ONCOLOGY |
Immunological Response Against SARS-COV-2 After BNT162b2 Vaccine Administration Is Impaired in Allogeneic but Not in Autologous Stem Cell Transplant Recipients |
2021-09-06 |
10.3389/fonc.2021.737300 |
Chiarucci Martina, Paolasini Sara, Isidori Alessandro, Guiducci Barbara, Loscocco Federica, Capalbo Maria, Visani Giuseppe |
| 738487 |
FRONTIERS IN ONCOLOGY |
The Ratio of Preoperative Serum Biomarkers Predicts Prognosis in Patients With Oral Squamous Cell Carcinoma |
2021-09-06 |
10.3389/fonc.2021.719513 |
Ding Meng, Song Yuxian, Jing Junyan, Tian Mei, Ding Liang, Li Qiang, Zhou Chongchong, Dong Heng, Ni Yanhong, Mou Yongbin |
| 738486 |
FRONTIERS IN ONCOLOGY |
Biological Role and Clinical Implications of microRNAs in BRCA Mutation Carriers |
2021-09-06 |
10.3389/fonc.2021.700853 |
Tommasi Chiara, Pellegrino Benedetta, Boggiani Daniela, Sikokis Angelica, Michiara Maria, Uliana Vera, Bortesi Beatrice, Bonatti Francesco, Mozzoni Paola, Pinelli Silvana, Squadrilli Anna, Viani Maria Vittoria, Cassi Diana, Maglietta Giuseppe, Meleti Marco, Musolino Antonino |
| 738485 |
FRONTIERS IN ONCOLOGY |
A New Clinical Nomogram From the TCGA Database to Predict the Prognosis of Hepatocellular Carcinoma |
2021-09-06 |
10.3389/fonc.2021.698980 |
Ye Dingde, Qu Jiamu, Wang Jian, Li Guoqiang, Sun Beicheng, Xu Qingxiang |
| 738484 |
FRONTIERS IN ONCOLOGY |
A Nomogram for the Determination of the Necessity of Concurrent Chemotherapy in Patients With Stage II–IVa Nasopharyngeal Carcinoma |
2021-09-06 |
10.3389/fonc.2021.640077 |
Yang Kaixuan, Zhang Qian, Zhang Mengxi, Xie Wenji, Li Mei, Zeng Lei, Wang Qiang, Zhao Jianling, Li Yiping, Li Guangjun |
| 738483 |
FRONTIERS IN ONCOLOGY |
A Functional Polymorphism in Accessible Chromatin Region Confers Risk of Non-Small Cell Lung Cancer in Chinese Population |
2021-09-06 |
10.3389/fonc.2021.698993 |
Long Jieyi, Long Tingting, Li Ying, Yuan Peihong, Liu Ke, Li Jiaoyuan, Cheng Liming |
| 738482 |
FRONTIERS IN ONCOLOGY |
Adverse Events as a Potential Clinical Marker of Antitumor Efficacy in Ovarian Cancer Patients Treated With Poly ADP-Ribose Polymerase Inhibitor |
2021-09-06 |
10.3389/fonc.2021.724620 |
Ni Jing, Cheng Xianzhong, Zhou Rui, Zhao Qian, Xu Xia, Guo Wenwen, Gu Hongyuan, Chen Chen, Chen Xiaoxiang |
| 738481 |
FRONTIERS IN ONCOLOGY |
DNA Methylation Regulator-Meditated Modification Patterns Define the Distinct Tumor Microenvironment in Lung Adenocarcinoma |
2021-09-06 |
10.3389/fonc.2021.734873 |
Yuan Didi, Wei Zehong, Wang Yicheng, Cheng Fang, Zeng Yujie, Yang Li, Zhang Shangyu, Li Jianbo, Tang Renkuan |
| 738480 |
FRONTIERS IN ONCOLOGY |
Overexpression of Circular RNA circ_0013587 Reverses Erlotinib Resistance in Pancreatic Cancer Cells Through Regulating the miR-1227/E-Cadherin Pathway |
2021-09-06 |
10.3389/fonc.2021.754146 |
Xu Huiting, Chen Runzhi, Shen Qian, Yang Dongmei, Peng Hui, Tong Jin, Fu Qiang |
| 738479 |
FRONTIERS IN ONCOLOGY |
ALK Rearrangement–Positive Pancreatic Cancer with Brain Metastasis Has Remarkable Response to ALK Inhibitors: A Case Report |
2021-09-06 |
10.3389/fonc.2021.724815 |
Ou Kai, Liu Xiu, Li Weihua, Yang Yi, Ying Jianming, Yang Lin |
